Store
2026 Nuclear Medicine Market Outlook Report
Publication Date: May 15, 2026
Tags: Nuclear Medicine
Pages: 167
SKU: 26-062
IMV’s 2026 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light of industry challenges. The report explores nuclear medicine market trends, including NM procedure volume, installed base features, use of OEM vs. third-party service providers, equipment purchase plans, radiopharmaceutical utilization/budgets, theranostics, and site operations characteristics. Survey results are projected to the identified universe of NM facilities.
What you’ll learn in this report
Nuclear medicine department priorities and future outlook
- What are the key department priorities for NM?
- What factors will impact the outlook for NM the most?
- What are the preferred info sources for future NM purchases?
- What are the top-ranked preferred uses of AI for NM?
Nuclear medicine procedures
- How has NM volume changed in 2026?
- What is the trend in NM procedure mix by procedure type?
NM scanner installed base and purchase plans
- How many fixed NM units are installed by site type?
- What is the trend in installed base market share by vendor?
- What is the adoption rate for key NM capabilities?
- What is the anticipated age of NM units upon replacement?
- What is the mix of new vs. refurbished NM scanners?
- What type of service providers are NM sites using?
- What is the brand loyalty of current NM users?
- What are the key buying criteria for future NM scanners?
- What is the unit forecast for NM scanners for 2026 to 2028?
Theranostics
- What are the most common theranostics procedures?
- Which radiopharmaceuticals are utilized the most?
Site operations characteristics
- How many technologists, nurses, administrators, imaging aides, and secretaries are employed in NM departments?
- What % of sites & procedures use outside reading services
Market Research Methodology
This report utilizes the results from an IMV-hosted online survey conducted in February/April 2026 with 300 NM administrators, supervisors, and chief technologists from a random sample of hospitals and imaging centers in the US.
2026 NUCLEAR MEDICINE MARKET OUTLOOK REPORT
| Insight to Impact: How to Utilize this Report for Strategic Advantage | 6 |
| Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2026 Survey | 13 |
| Hospitals vs. Non-Hospitals: Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2026 Survey | 14 |
| Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, by Site Type, as of 2026 Survey | 15 |
| Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, by IMV Study Year, 2011 to 2026 | 16 |
| Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, as of 2026 Survey | 17 |
| Hospitals vs. Non-Hospitals: Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, as of 2026 Survey | 18 |
| Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, by Site Type, as of 2026 Survey | 19 |
| Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, by IMV Study Year, 2011 to 2026 | 20 |
| Priority Ranking for Using Artificial Intelligence and Machine Learning Tools in NM Departments, as of 2026 Survey | 21 |
| #1/#2 Priority Ranking for Using Artificial Intelligence and Machine Learning Tools in NM Departments, by Site Type, as of 2026 Survey | 22 |
| Current Use and Consideration of Artificial Intelligence and Machine Learning Tools in NM Departments, as of 2026 Survey | 23 |
| Current Use and Consideration of Artificial Intelligence and Machine Learning Tools in Nuclear Medicine Departments, by Hospital vs. Non-Hospital, as of 2026 Survey | 24 |
| Current Use of Artificial Intelligence and Machine Learning Tools in Nuclear Medicine Departments, by Site Type, as of 2026 Survey | 25 |
| Outlook for NM Procedures, Reimbursement, Revenue, and Net Income, Compared to 2025 | 26 |
| Outlook for NM Procedure Volume and Revenue, by IMV Study Year, 2011 to 2026 | 27 |
| Strategic Actions Being Considered Over the Next Few Years, as of 2026 Survey | 28 |
| Strategic Actions Being Considered Over the Next Few Years, by Hospital vs. Non-Hospitals, as of 2026 Survey | 29 |
| Strategic Actions Being Considered Over the Next Few Years, by Site Type, as of 2026 Survey | 30 |
| AI Impact on NM Department in 2025 – Summary of Open-Ended Responses | 31 |
| Anticipated AI Impact on NM Department in 2026 – Summary of Open-Ended Responses | 32 |
| NM Equipment & Services Suggestions – Summary of Open-Ended Responses | 33 |
| Total Nuclear Medicine Patient Studies, Hospital and Non-Hospital Sites, 2002 to 2025 | 35 |
| Distribution of Nuclear Medicine Sites and Patient Studies, by Site Type, 2026 | 36 |
| Trend in Average Nuclear Medicine Patient Studies per Site, by Site Type, 2017 to 2025 | 37 |
| Distribution of 2025 Nuclear Medicine Patient Studies Performed on SPECT-CT, SPECT-only and Planar-only Cameras, by Site Type | 38 |
| Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, as of 2026 Survey | 39 |
| Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, by Site Type, as of 2026 Survey | 40 |
| Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, by Site Type, as of 2026 Survey (continued) | 41 |
| Nuclear Medicine 2025 Patient Study Mix, by Procedure Category, All Sites | 42 |
| Distribution of Nuclear Medicine Patient Studies, by Procedure Type, 2018 to 2025 | 43 |
| Distribution of Nuclear Medicine Patient Studies, by Procedure Type, Hospitals and Non-Hospitals, 2010 to 2025 | 44 |
| Whether the Total Number of NM Patient Studies in 2026 is Anticipated to Increase, Stay the Same, or Decrease, Compared to 2025, by Site Type | 45 |
| Whether Proportion of NM Patient Studies Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025, by Procedure Type | 46 |
| Percent of Sites Performing Nuclear Medicine Studies and Average Annual Nuclear Medicine Patient Studies per Site Performing, by Procedure Type, Hospitals and Non-Hospitals, as of 2026 Survey | 47 |
| Percent of Sites Performing Nuclear Medicine Studies, by Procedure Type, by IMV Study Year, 2018 to 2025 | 48 |
| Mix of Inpatient, Outpatient, vs. Emergency Nuclear Medicine Patient Studies, by Site Type, 2025 | 49 |
| Percentage of SPECT/CT Sites Performing Patient Studies with Diagnostic CT Scans, as of 2026 Survey | 50 |
| Percentage of SPECT/CT Sites Performing Diagnostic CT-only Scans with No Associated SPECT Scans, as of 2026 Survey | 51 |
| Distribution of Nuclear Medicine Sites and Cameras, Hospital & Non-Hospital Sites, as of 2026 Survey | 53 |
| Trend in Installed Base of Nuclear Medicine Cameras, Hospital & Non-Hospital Sites, by IMV Study Year, 2011 to 2026 | 54 |
| Distribution of Sites, by Number of Nuclear Medicine Cameras Installed, by Site Type, as of 2026 Survey | 55 |
| Nuclear Medicine Camera Installed Base Share, by Manufacturer, as of 2026 Survey | 56 |
| Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation, as of 2026 Survey | 57 |
| Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation, by Site Type, as of 2026 Survey | 58 |
| Distribution of Nuclear Medicine Cameras Installed Base, by Camera Type, by Site Type, as of 2026 Survey | 59 |
| Trend in Nuclear Medicine Camera Installed Base Mix, by Camera Type, by IMV Study Year, 2011 to 2026 | 60 |
| Nuclear Medicine Camera Installed Base Share, by Camera Type, as of 2026 Survey | 61 |
| Nuclear Medicine Camera Installed Base Share, for Units Installed in the Last 6 Years, as of 2026 Survey | 62 |
| Distribution of Installed SPECT/CT Cameras, by Number of CT Slices, as of 2026 Survey | 63 |
| Whether the SPECT or SPECT/CT is a General Purpose or Dedicated Cardiac Camera, by Site Type, as of 2026 Survey | 64 |
| Whether the SPECT or SPECT/CT has a Solid State Detector, by Site Type, as of 2026 Survey | 65 |
| Whether the SPECT or SPECT/CT was Purchased New or Refurbished, by Site Type, as of 2026 Survey | 66 |
| Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras, by Site Type, as of 2026 Survey | 67 |
| Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras, by Year Installed, as of 2026 Survey | 68 |
| Type of Service Contractual Arrangement for Nuclear Medicine Cameras, by Site Type, as of 2026 Survey | 69 |
| Primary Source of NM Service Support, by Whether the SPECT or SPECT/CT was Originally Purchased New or Refurbished, as of 2026 Survey | 70 |
| Purchase Plans for Nuclear Medicine Cameras Over the Next Three Years, as of 2026 Survey | 72 |
| Percent of Sites Planning to Purchase Nuclear Medicine Cameras Over the Next Three Years, by IMV Study Year, 2011 to 2026 | 73 |
| Type of Nuclear Medicine Camera Planned for Purchase, as of 2026 Survey | 74 |
| Type of Nuclear Medicine Cameras Planned for Purchase, by IMV Study Year, 2011 to 2026 | 75 |
| Whether Planned Nuclear Medicine Cameras Will be a General Purpose or Dedicated Cardiac Camera, as of 2026 Survey | 76 |
| Planned SPECT/CT Cameras, by Number of CT Slices, as of 2026 Survey | 77 |
| Plans for New vs. Refurbished Nuclear Medicine Cameras, by Site Type, as of 2026 Survey | 78 |
| Plans for Replacement and Additional Nuclear Medicine Cameras, as of 2026 Survey | 79 |
| Percent Distribution of Sites Mentioning Manufacturers Considered for Next Nuclear Medicine Camera Purchase, as of 2026 Survey | 80 |
| Brand Loyalty: Nuclear Medicine Camera Manufacturers Being Considered, by Current Camera Installed Base, as of 2026 Survey | 81 |
| Annual 2026-2028 Budget Status for All Cameras Planned for Purchase, as of 2026 Survey | 82 |
| Distribution of 2026 Nuclear Medicine Equipment Budgets, as of 2026 Survey | 83 |
| Distribution of 2025-2028 NM Equipment Budgets, as of 2026 Survey | 84 |
| Distribution of 2025-2028 NM Equipment Budgets, by Site Type, as of 2026 Survey | 85 |
| Average Nuclear Medicine Equipment Budget per Site, by Site Type, by IMV Study Year, 2018 to 2026 | 86 |
| Percentage of Sites Planning to Complete Capital Projects from 2026 to 2028, as of 2026 Survey | 87 |
| Nuclear Medicine Camera Replacement Cycle, Based on 2026 Survey Responses | 88 |
| Facilities Performing Radionuclide Therapy, by Site Type, as of 2026 Survey | 90 |
| Radionuclide Therapy: Distribution of Nuclear Medicine Sites Performing and Procedures Performed, by Site Type, 2025 | 91 |
| Percentage of Radionuclide Therapy Sites Using Radionuclide Therapy Agents and Radionuclide Therapy Procedure Volume, by Radionuclide Agents, 2025 | 92 |
| Facilities Performing Theranostics, by Site Type, as of 2026 Survey | 93 |
| Theranostics: Distribution of Nuclear Medicine Sites Performing and Procedures Performed, by Site Type, 2025 | 94 |
| Percentage of Theranostics Sites Using Specific Radiopharmaceutical Agents and Theranostics Procedure Volume, by Radiopharmaceutical Agents, 2025 | 95 |
| Were PSMA Radiopharmaceuticals Used for Any NM SPECT/CT or SPECT Scans in Your Department, as of 2026 Survey | 96 |
| Myocardial Perfusion Studies: Distribution of NM Sites Performing and Patient Studies, by Site Type, 2025 | 97 |
| Radioactive Agent Used for Myocardial Perfusion Studies, Including Single & Dual Isotopes, 2025 | 98 |
| Percent of Myocardial Perfusion Studies Using Single vs. Dual Isotopes, by Site Type, 2025 | 99 |
| Percentage of Myocardial Perfusion Studies, Using Specified Agents, by Site Type, 2025 | 100 |
| Percentage of Sites Providing Perfusion Injections, by Injection Type, 2026 | 101 |
| Distribution of Perfusion Injections, by Isotope, by Site Type, 2025 | 102 |
| Whether the Proportion of Myocardial Perfusion Patient Studies Using Technetium-99m Agents Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025 | 103 |
| Distribution of 2025 Myocardial Perfusion Patient Studies, by Whether Imaged with Stress or Not, by Site Type | 104 |
| Distribution of 2025 Myocardial Perfusion Patient Studies, by Stress Mode, Hospitals and Non-Hospitals | 105 |
| Percent of Myocardial Perfusion Studies Using Pharmaceutical Stress Agents, by Stress Agent, by Site Type, 2025 | 106 |
| Distribution of 2026 Radiopharmaceutical Budgets, as of 2026 Survey | 107 |
| Radiopharmaceutical Expenditures, Hospital and Non-Hospital Sites, 2012 to 2026 | 108 |
| Average Radiopharmaceutical Expenditures per Site and per Patient Study, by Site Type, 2026 | 109 |
| Whether the Price per Patient Dose for Technetium-99m Agents Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025 | 110 |
| Distribution of Nuclear Medicine Sites, by Source of Radiopharmaceuticals, by Site Type, as of 2026 Survey | 111 |
| Supplier Share of 2025 Radiopharmaceutical Expenditures, by Site Type | 112 |
| Distribution of Hospital vs. Non-Hospital Nuclear Medicine Sites, as of 2026 Survey | 114 |
| Distribution of IMV-Identified Hospital-Based Nuclear Medicine Sites, by Hospital Bed Size, as of 2026 Survey | 115 |
| Urban/Suburban/Rural Locations, by Site Type, as of 2026 Survey | 116 |
| Percent of Nuclear Medicine Sites with Specified Staff Types, by Site Type, as of 2026 Survey | 117 |
| Whether Facility has a Nuclear Medicine Physicist on Staff, by Site Type, as of 2026 Survey | 118 |
| Distribution of Sites by Number of Physicians that Read Nuclear Medicine Studies, by Site Type, as of 2026 Survey | 119 |
| Specialties of Physicians Who Read Nuclear Medicine Studies, by Site Type, as of 2026 Survey | 120 |
| Percentage of NM Sites Read On-Site by Physicians at the Imaging Facility, by Site Type, as of 2026 Survey | 121 |
| Types of Digital Workstations Used by Physicians for Reading and Interpreting NM Exams, by Site Type, as of 2026 Survey | 122 |
| Financial Health of Nuclear Medicine Department in 2026, by Site Type | 123 |
| Financial Health of Nuclear Medicine Department in Recent Years, as of 2026 Survey | 124 |
| Whether Nuclear Medicine Department is at Optimal Staffing Levels, as of 2026 Survey | 125 |
| Level of Staffing Challenges in Nuclear Medicine Department, by Site Type, as of 2026 Survey | 126 |
| Average Waiting Time for a Non-Emergency NM Outpatient Visit, by IMV Study Year, 2011 to 2026 | 127 |
| Average Waiting Time for a Non-Emergency NM Outpatient Visit, Hospitals vs. Non-Hospitals, as of 2026 Survey | 128 |
| Hours per Weekday Nuclear Medicine Department Open for Scheduled Procedures, by Site Type, as of 2026 Survey | 129 |
| Hours per Weekday Nuclear Medicine Department Open Including Scheduled, Unscheduled, and On-Call Procedures, by Site Type, as of 2026 Survey | 130 |
| NM Department Financial Health Outlook – Summary of Open-Ended Responses | 131 |
| NM Department Staffing Challenges – Summary of Open-Ended Responses | 132 |
| AI Impact on NM Department in 2025 – Open-Ended Responses | 134 |
| AI Impact on NM Department in 2025 – Open-Ended Responses (continued) | 135 |
| AI Impact on NM Department in 2025 – Open-Ended Responses (continued) | 136 |
| AI Impact on NM Department in 2025 – Open-Ended Responses (continued) | 137 |
| Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses | 138 |
| Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued) | 139 |
| Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued) | 140 |
| Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued) | 141 |
| Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued) | 142 |
| NM Department Financial Health Outlook – Open-Ended Responses | 143 |
| NM Department Financial Health Outlook – Open-Ended Responses (continued) | 144 |
| NM Department Financial Health Outlook – Open-Ended Responses (continued) | 145 |
| NM Department Financial Health Outlook – Open-Ended Responses (continued) | 146 |
| NM Department Financial Health Outlook – Open-Ended Responses (continued) | 147 |
| NM Department Staffing Challenges – Open-Ended Responses | 148 |
| NM Department Staffing Challenges – Open-Ended Responses (continued) | 149 |
| NM Department Staffing Challenges – Open-Ended Responses (continued) | 150 |
| NM Department Staffing Challenges – Open-Ended Responses (continued) | 151 |
| NM Department Staffing Challenges – Open-Ended Responses (continued) | 152 |
| NM Department Staffing Challenges – Open-Ended Responses (continued) | 153 |
| NM Equipment & Services Suggestions – Open-Ended Responses | 154 |
| NM Equipment & Services Suggestions – Open-Ended Responses (continued) | 155 |
| NM Equipment & Services Suggestions – Open-Ended Responses (continued) | 156 |
| NM Equipment & Services Suggestions – Open-Ended Responses (continued) | 157 |
| Methodology | 158 |
| About IMV | 167 |
Related products
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
Price range: $5,000.00 through $7,875.00
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
March 7, 2024
Explore the cutting-edge world of molecular point-of-care (mPOC) diagnostic solutions with our latest report, offering a detailed analysis of the market and future growth potential from 2023-2028. mPOC technology revolutionizes diagnostic capabilities, providing enhanced sensitivity and specificity compared to traditional near-patient tests. These solutions are instrumental in critical care units, physician offices, outpatient clinics,…
Price range: $5,000.00 through $7,875.00
The World Market for Vaccines, 2024
February 22, 2024
Vaccines are a cornerstone of preventive medicine, offering long-term or permanent immunity against diseases. They have been instrumental in near-eliminating many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Kalorama Information’s latest report, The World Market for Vaccines, 2024, provides a comprehensive analysis of adult…
Price range: $5,000.00 through $7,875.00
